SPOTLIGHT: Bill bars trade rep block on drug imports

In a bid to make drug importation easier, House and Senate lawmakers introduced a bill that would keep US trade representatives from striking deals to keep internationally manufactured drugs off the market. Recent trade agreements with Singapore, Australia and Morocco require the consent of drug patent owners to import drugs for sale in the US, which would effectively prevent the practice. Story

Suggested Articles

AbbVie snagged the option to license Harpoon’s anti-BCMA multiple myeloma candidate and the duo added up to six new targets to their discovery deal.

In this week's EuroBiotech Report, Bayer's heart failure drug clears phase 3 test, ABPI calls for more U.K. investment and GHO raises €975 million. 

In our EuroBiotech roundup this week, Azeria raises £32 million, Zealand delays phase 3 readout and Galapagos eyes early 2021 IPF futility analysis.